<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04133714</url>
  </required_header>
  <id_info>
    <org_study_id>2019-XXX</org_study_id>
    <nct_id>NCT04133714</nct_id>
  </id_info>
  <brief_title>A Multi-center RCT Study on the Efficacy and Mechanism of Multi-channel tDCS in Rehabilitation of Cognitive Function After Stroke</brief_title>
  <official_title>A Multi-center RCT Study on the Efficacy and Mechanism of Multi-channel tDCS in Rehabilitation of Cognitive Function After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical RCT study intends to combined different forms of multi-channel tDCS with the
      routine cognitive training process to treat patients with post-stroke cognitive dysfunction.

      The therapeutic effects among single-channel tDCS group, multi-channel tDCS and
      pseudo-multichannel tDCS group will be compared. Brain magnetic resonance mechanism research
      will also be included to reveal the possible mechanism of multi-channel tDCS technology for
      PSCI brain network.

      Thus, the efficacy and mechanism of multi-channel tDCS in post-stroke cognitive function
      rehabilitation will be researched both in the clinical and basic levels.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MMSE</measure>
    <time_frame>Change from Baseline MMSE at 2 weeks and 3 months after intervention</time_frame>
    <description>Mini-mental State Examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MoCA</measure>
    <time_frame>Change from Baseline MoCA at 2 weeks and 3 months after intervention</time_frame>
    <description>Montreal Cognitive Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AVLT</measure>
    <time_frame>Change from Baseline AVLT at 2 weeks and 3 months after intervention</time_frame>
    <description>The Auditory-Verbal Learning Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WAIS-DST</measure>
    <time_frame>Change from Baseline WAIS-DST at 2 weeks and 3 months after intervention</time_frame>
    <description>WAIS Digit Symbol Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>DEX</measure>
    <time_frame>Change from Baseline DEX at 2 weeks and 3 months after intervention</time_frame>
    <description>Dysexecutive Ques-tionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GNAT</measure>
    <time_frame>Change from Baseline GNAT at 2 weeks and 3 months after intervention</time_frame>
    <description>Go/No-go Association Task</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>multi-channel tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the multi-channel tDCS stimulation group, a 1:4 (anode: cathode) approach was applied, with the central anode placed in the left dorsolateral prefrontal cortex (dlPFC) (reference 10-20 standard lead EEG), and the remaining cathode distributed around the central electrode.
The rising time and falling time of current are 30 seconds respectively. Stimulate 30 minutes daily for 10 days (Monday to Friday, once a day, weekend off).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>single-channel tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The anode electrode of the single-channel tDCS stimulation group was placed in the left dlPFC, and the cathode electrode was placed in the right orbital forehead.
The rising time and falling time of current are 30 seconds respectively. Stimulate 30 minutes daily for 10 days (Monday to Friday, once a day, weekend off).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>The shame stimulation group had only 30 seconds of up and down stimulation, with no intermediate stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>multi-channel tDCS</intervention_name>
    <description>multi-channel transcranial direct current stimulation, tDCS</description>
    <arm_group_label>multi-channel tDCS</arm_group_label>
    <arm_group_label>sham stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>single-channel tDCS</intervention_name>
    <description>single-channel transcranial direct current stimulation</description>
    <arm_group_label>sham stimulation</arm_group_label>
    <arm_group_label>single-channel tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 year-old

          -  diagnosed cerebral apoplexy, meeting the diagnostic criteria of ICD-10

          -  cognitive function, perceptual function decline after stroke

          -  first onset and duration of 3-12 months

          -  right-handed

          -  MMSE ≤25

          -  MoCA ≤25

          -  sign informed consent voluntarily and comply with the study plan

        Exclusion Criteria:

          -  NIHSS ≥21 points

          -  MoCA ≤18, or DRS-2 ≤ 124, or CES-D ≥ 16

          -  taking drugs that affect central nervous activity, such as nerve antagonists

          -  specific contraindication, such as electrode patch allergy, local skin injury or - - -
             - inflammation, and hyperalgesia in stimulated areas

          -  patients use implantable electronic devices (such as cardiac pacemakers) or have -
             metal implants such as stents that affect MRI examination

          -  patients with a previous history of epilepsy, mental illness or skull injury

          -  patients with dementia or obvious cognitive dysfunction before stroke

          -  patients with aphasia or dysarthria and cannot complete the scale evaluation

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hongjie Jiang, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ruidong Cheng, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhejiang Provincial People’s Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rang Wang, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rainbowfish Rehabilitation Nursing Care</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jingming Hou, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southwest Hospital, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hongjie Jiang, Dr.</last_name>
    <phone>+86 13777830137</phone>
    <email>insjhj@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rainbowfish Rehabilitation Nursing Care</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ran Wang, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SAHZhejiangU</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongjie Jiang, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhejiang Provincial People's Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310014</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruidong Cheng, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <zip>400000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingming Hou, Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 14, 2019</study_first_submitted>
  <study_first_submitted_qc>October 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 21, 2019</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

